Related Experiment Video
Updated: Apr 16, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2
Guangfeng Niu1, Bin Li1, Li Sun1
1Department of Orthopaedics, Shandong Provincial Hospital affiliated to Shandong University, Shandong University, Jinan, P.R. China.
Abstract:
Increasing evidence indicates that microRNAs (miRNAs), a class of small noncoding RNAs, participate in almost every step of cellular processes. MiRNAs are aberrantly expressed in human cancers and contribute to cancer development and progression. Study of miRNAs may provide a new clue for understanding the mechanism of carcinogenesis and a new tool for cancer treatment. In the present study, miR-153 was downregulated in human osteosarcoma tissues and cell lines. Introduction of miR-153 mimics into the MG-63 cells inhibited cell proliferation and invasion. Our results further revealed that transforming growth factor beta 2 (TGF-β2) was negatively regulated by miR-153. Furthermore, overexpression of miR-153 decreased p-SMAD2, p-SMAD3, epidermal growth factor receptor (EGFR) and insulin-like growth factor binding protein-3 (IGFBP-3) expressions, which were the downstream signaling molecules of TGF-β. Furthermore, miRNA-153 suppressed TGF-β-mediated MG-63 proliferation and migration. Therefore, our results suggest that miR-153 may act as a tumor suppressor in osteosarcoma through targeting TGF-β2.
Insights
MicroRNA-153 (miR-153) acts as a tumor suppressor in osteosarcoma. This study found miR-153 inhibits osteosarcoma cell proliferation and invasion by targeting transforming growth factor beta 2 (TGF-β2).
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs crucial for cellular processes.
- Aberrant miRNA expression is linked to cancer development and progression.
- miRNAs offer potential for cancer mechanism understanding and novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of miR-153 in human osteosarcoma.
- To identify the molecular targets and pathways regulated by miR-153 in osteosarcoma cells.
Main Methods:
- Quantitative real-time PCR to assess miR-153 expression in osteosarcoma tissues and cell lines.
- Transfection of miR-153 mimics into MG-63 osteosarcoma cells.
- Western blotting to analyze the expression of downstream signaling molecules.
- Cell proliferation and migration assays.
Main Results:
- miR-153 was significantly downregulated in human osteosarcoma tissues and cell lines.
- Overexpression of miR-153 inhibited MG-63 cell proliferation and invasion.
- miR-153 directly targeted and negatively regulated transforming growth factor beta 2 (TGF-β2).
- miR-153 overexpression reduced the expression of TGF-β signaling pathway components (p-SMAD2, p-SMAD3, EGFR, IGFBP-3).
Conclusions:
- miR-153 functions as a tumor suppressor in osteosarcoma.
- The tumor-suppressive role of miR-153 is mediated through the inhibition of the TGF-β2 signaling pathway.
- miR-153 represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

